Protalix BioTherapeutics Inc (PLX) - Financial and Strategic SWOT Analysis Review

  • ID: 4278518
  • SWOT Analysis
  • 25 pages
  • GlobalData
  • Protalix Biotherapeutics
1 of 5

Protalix BioTherapeutics Inc (Protalix) is a biopharmaceutical company that develops and commercializes recombinant therapeutic proteins. The company’s marketed product, Taliglucerase (taliglucerase alfa) is an enzyme replacement therapy (ERT) for the long-term treatment of adult patients with a confirmed diagnosis of type 1 Gaucher disease. Its pipeline products include PRX-102, a therapeutic enzyme for the treatment of Fabry disease; PRX-110, a plant cell-expressed recombinant form of human deoxyribonuclease I and is intended for the treatment of cystic fibrosis. Its PRX-106 is an orally delivered anti inflammatory treatment; and PRX-112, a oral glucocerebrosidase for gaucher disease. Protalix develops its proprietary pipeline of recombinant therapeutic proteins through its procellex, which is a plant cell-based expression technology. The company operates through various pharmaceutical companies, scientific institutions and governmental agencies. Protalix is headquartered in Carmiel, Israel.

Protalix BioTherapeutics Inc Key Recent Developments

Mar 06, 2018: Protalix BioTherapeutics Reports 2017 Full Year Results and Provides Corporate Update
Nov 26, 2017: Biomed Company Protalix to lay off a fifth of its workforce
Nov 08, 2017: Protalix BioTherapeutics Reports 2017 Third Quarter Results and Provides Corporate Update
Aug 09, 2017: Protalix BioTherapeutics Reports 2017 Second Quarter Results and Provides Corporate Update
Mar 16, 2017: Protalix BioTherapeutics Reports 2016 Full Year Results and Provides Corporate Update

This comprehensive SWOT profile of Protalix BioTherapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Protalix BioTherapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 5
Section 1 - About the Company
  • Protalix BioTherapeutics Inc - Key Information
  • Protalix BioTherapeutics Inc - Overview
  • Protalix BioTherapeutics Inc - Key Employees
  • Protalix BioTherapeutics Inc - Key Employee Biographies
  • Protalix BioTherapeutics Inc - Key Operational Heads
  • Protalix BioTherapeutics Inc - Major Products and Services
  • Protalix BioTherapeutics Inc - History
  • Protalix BioTherapeutics Inc - Company Statement
  • Protalix BioTherapeutics Inc - Locations And Subsidiaries
  • Protalix BioTherapeutics Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Protalix BioTherapeutics Inc - Business Description
  • Protalix BioTherapeutics Inc - Corporate Strategy
  • Protalix BioTherapeutics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Protalix BioTherapeutics Inc - Strengths
  • Protalix BioTherapeutics Inc - Weaknesses
  • Protalix BioTherapeutics Inc - Opportunities
  • Protalix BioTherapeutics Inc - Threats
  • Protalix BioTherapeutics Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Protalix BioTherapeutics Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Protalix BioTherapeutics Inc, Key Information
  • Protalix BioTherapeutics Inc, Key Ratios
  • Protalix BioTherapeutics Inc, Share Data
  • Protalix BioTherapeutics Inc, Major Products and Services
  • Protalix BioTherapeutics Inc, History
  • Protalix BioTherapeutics Inc, Key Employees
  • Protalix BioTherapeutics Inc, Key Employee Biographies
  • Protalix BioTherapeutics Inc, Key Operational Heads
  • Protalix BioTherapeutics Inc, Other Locations
  • Protalix BioTherapeutics Inc, Subsidiaries
  • Protalix BioTherapeutics Inc, Key Manufacturing facilities
  • Protalix BioTherapeutics Inc, Key Competitors
  • Protalix BioTherapeutics Inc, SWOT Analysis
  • Protalix BioTherapeutics Inc, Ratios based on current share price
  • Protalix BioTherapeutics Inc, Annual Ratios
  • Protalix BioTherapeutics Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Protalix BioTherapeutics Inc, Performance Chart
  • Protalix BioTherapeutics Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 5


4 of 5
  • Teva Pharmaceutical Industries Ltd
  • Can-Fite BioPharma Ltd
  • BiondVax Pharmaceuticals Ltd
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown